Peroxisome proliferator-activated receptor gamma (PPARgamma): Is the genomic activity the only answer?
about
Regulation of EPCs: The Gateway to Blood Vessel FormationBreaking the mold: transcription factors in the anucleate platelet and platelet-derived microparticlesInhibition of FAAH and activation of PPAR: new approaches to the treatment of cognitive dysfunction and drug addictionChanges in DNA Methylation in Mouse Lungs after a Single Intra-Tracheal Administration of NanomaterialsLow intensity pulsed ultrasound (LIPUS) influences the multilineage differentiation of mesenchymal stem and progenitor cell lines through ROCK-Cot/Tpl2-MEK-ERK signaling pathwayRoles of PPARγ/NF-κB signaling pathway in the pathogenesis of intrahepatic cholestasis of pregnancy.Minireview: Challenges and opportunities in development of PPAR agonistsLow birth weight male guinea pig offspring display increased visceral adiposity in early adulthood.Cross regulation of sirtuin 1, AMPK, and PPARγ in conjugated linoleic acid treated adipocytes.Pioglitazone rapidly reduces neuropathic pain through astrocyte and nongenomic PPARγ mechanismsCellular and molecular effects of thiazolidinediones on bone cells: a review.Protein Kinase C Is Involved in the Induction of ATP-Binding Cassette Transporter A1 Expression by Liver X Receptor/Retinoid X Receptor Agonist in Human Macrophages.Rosiglitazone Restores Endothelial Dysfunction in a Rat Model of Metabolic Syndrome through PPARγ- and PPARδ-Dependent Phosphorylation of Akt and eNOS.Peroxisome proliferator-activated receptor-γ agonists repress epithelial sodium channel expression in the kidney.Improved insulin sensitivity after treatment with PPARγ and PPARα ligands is mediated by genetically modulated transcripts.Thiazolidinediones induce osteocyte apoptosis by a G protein-coupled receptor 40-dependent mechanism.Regulation of Matrix Remodeling by Peroxisome Proliferator-Activated Receptor-γ: A Novel Link Between Metabolism and Fibrogenesis.Peroxisome Proliferator-Activated Receptors and the Heart: Lessons from the Past and Future Directions.Mechanisms of chronic state of inflammation as mediators that link obese adipose tissue and metabolic syndromeThe role of peroxisome proliferator-activated receptor γ in pancreatic β cell function and survival: therapeutic implications for the treatment of type 2 diabetes mellitus.Targeting the peroxisome proliferator-activated receptors (PPARs) in spinal cord injury.Modes-of-Action Related to Repeated Dose Toxicity: Tissue-Specific Biological Roles of PPAR γ Ligand-Dependent Dysregulation in Nonalcoholic Fatty Liver Disease.Thiazolidinedione drugs in the treatment of type 2 diabetes mellitus: past, present and future.Integrated proteomic and metabolomic analysis to assess the effects of pure and benzo[a]pyrene-loaded carbon black particles on energy metabolism and motility in the human endothelial cell line EA.hy926.Expression of Peroxisome Proliferator Activated Receptor gamma in Prostatic Adenocarcinoma.Delta-9-tetrahydrocannabinol protects against MPP+ toxicity in SH-SY5Y cells by restoring proteins involved in mitochondrial biogenesis.Peroxisome proliferator-activated receptor gamma and regulations by the ubiquitin-proteasome system in pancreatic cancerPPARgamma Deficiency Counteracts Thymic Senescence.Ginsenoside Rg3 stereoisomers differentially inhibit vascular smooth muscle cell proliferation and migration in diabetic atherosclerosis.AMP-Activated Protein Kinase Mediates the Antiplatelet Effects of the Thiazolidinediones Rosiglitazone and Pioglitazone.Signaling Mechanisms of Selective PPAR Modulators in Alzheimer's Disease
P2860
Q21284530-2A66F4A0-4F05-45A7-9361-A1B2A81FCBC2Q26830366-AE85F8F2-CA61-4E11-BD58-8D62DD8CF1A4Q28283718-29A28933-7C3A-4B16-A75E-874517E72B11Q29248387-84766339-861C-4C47-8626-CD81AC10B73EQ30414463-11282232-47B3-468F-8191-1A19392E5687Q31149202-A33D2D47-4C3C-4571-923A-F81A14CDB304Q33631921-AAC37F3B-7D32-47DD-AAC5-14C3D1106F4FQ33753235-98344AAE-1B13-449B-984B-BF1B6C36CC23Q34479148-5151EB07-CF0C-4FC0-BD91-71DC990F84BDQ35085272-D08F22C5-3069-462E-97E9-9FC610333940Q35346767-3CD34D2B-8E7F-405C-AE53-8B08391EBAC4Q35573925-B73EA0C2-7F3E-4343-9DF4-B29201C64486Q35608658-DFA1386D-237C-47E5-97A7-6781D37FFD3BQ35964478-B410E3F2-80F3-45F4-B134-DC75278F2554Q36035534-08E16A42-4E3F-4C01-8D8D-D4187B18ADAAQ36078767-BEB164B3-044F-4C3D-8D57-BACC2E86647FQ36093802-7D13C8F6-34DE-4A24-AA88-6CB74235676BQ36261125-730ADC1C-332B-4333-B9E2-2C73A5F4D063Q36970120-C4FB69C4-D325-4E62-912F-2C4CBA95CF6CQ37150550-05EDF244-2F54-4CD7-9F4C-BCA5B38A2724Q37899155-A3B77D20-E6E1-4918-959C-2A76018E9F6AQ38207591-976D979D-0770-4E2E-8A7A-377112878832Q38641190-F8C2CA3D-920B-43A2-8186-081E4FA39CD2Q39030513-E91431BB-B870-4981-95D6-8799732B7829Q40088730-38A8A8F9-3FF8-435C-BD07-470715B69B7AQ40855302-285B454E-EF72-492D-985A-56A65F165D16Q42098281-FDEADA48-130A-4E82-AADB-290FEBCF557BQ47126451-72AE328E-2A67-4125-A3A5-1A0A867A65A9Q52642582-EF1FA6EE-6834-4798-A2F7-A363E58B03EDQ55034947-1B3F4F52-4D8E-4D6B-A2CD-ED974C05DBABQ58699276-1A84A687-8ABF-4FE6-9987-D1F91D7C74BF
P2860
Peroxisome proliferator-activated receptor gamma (PPARgamma): Is the genomic activity the only answer?
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Peroxisome proliferator-activa ...... omic activity the only answer?
@en
type
label
Peroxisome proliferator-activa ...... omic activity the only answer?
@en
prefLabel
Peroxisome proliferator-activa ...... omic activity the only answer?
@en
P1433
P1476
Peroxisome proliferator-activa ...... omic activity the only answer?
@en
P2093
Giulia Cantini
Mario Serio
P304
P356
10.1016/J.STEROIDS.2009.10.012
P577
2009-11-10T00:00:00Z